KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a poor overall prognosis. However, curative resection during the early stages of the disease can greatly improve survival rates, highlighting the importance of early screening and detection. Studies of noncoding RNAs, primarily microRN...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shuang-Ni Yu, Yi-Hui Ma, Wu-Gan Zhao, Xiang-Lan Jin, Hai-Yan Yang, Ping-Ping Liu, Jie Chen
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2016
Materias:
Acceso en línea:https://doaj.org/article/616dfffbe4b94d05bbfda3011c760d44
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:616dfffbe4b94d05bbfda3011c760d44
record_format dspace
spelling oai:doaj.org-article:616dfffbe4b94d05bbfda3011c760d442021-12-02T13:42:26ZKRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma2095-882X10.1016/j.cdtm.2016.11.012https://doaj.org/article/616dfffbe4b94d05bbfda3011c760d442016-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2095882X16300767https://doaj.org/toc/2095-882XPancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a poor overall prognosis. However, curative resection during the early stages of the disease can greatly improve survival rates, highlighting the importance of early screening and detection. Studies of noncoding RNAs, primarily microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), provide important insights into strategies for the early detection of KRAS-driven PDAC. Here, we summarize our studies and review current reports on research investigating KRAS-related miRNAs and lncRNAs, emphasizing their aberrant expression, mechanisms, carcinogenic effects, and prognostic and predictive capacities in PDAC. Keywords: Pancreatic ductal adenocarcinoma, KRAS, Noncoding RNAs, microRNAs, Long noncoding RNAsShuang-Ni YuYi-Hui MaWu-Gan ZhaoXiang-Lan JinHai-Yan YangPing-Ping LiuJie ChenKeAi Communications Co., Ltd.articleMedicine (General)R5-920ENChronic Diseases and Translational Medicine, Vol 2, Iss 4, Pp 215-222 (2016)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Shuang-Ni Yu
Yi-Hui Ma
Wu-Gan Zhao
Xiang-Lan Jin
Hai-Yan Yang
Ping-Ping Liu
Jie Chen
KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
description Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a poor overall prognosis. However, curative resection during the early stages of the disease can greatly improve survival rates, highlighting the importance of early screening and detection. Studies of noncoding RNAs, primarily microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), provide important insights into strategies for the early detection of KRAS-driven PDAC. Here, we summarize our studies and review current reports on research investigating KRAS-related miRNAs and lncRNAs, emphasizing their aberrant expression, mechanisms, carcinogenic effects, and prognostic and predictive capacities in PDAC. Keywords: Pancreatic ductal adenocarcinoma, KRAS, Noncoding RNAs, microRNAs, Long noncoding RNAs
format article
author Shuang-Ni Yu
Yi-Hui Ma
Wu-Gan Zhao
Xiang-Lan Jin
Hai-Yan Yang
Ping-Ping Liu
Jie Chen
author_facet Shuang-Ni Yu
Yi-Hui Ma
Wu-Gan Zhao
Xiang-Lan Jin
Hai-Yan Yang
Ping-Ping Liu
Jie Chen
author_sort Shuang-Ni Yu
title KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
title_short KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
title_full KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
title_fullStr KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
title_full_unstemmed KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma
title_sort kras-related noncoding rnas in pancreatic ductal adenocarcinoma
publisher KeAi Communications Co., Ltd.
publishDate 2016
url https://doaj.org/article/616dfffbe4b94d05bbfda3011c760d44
work_keys_str_mv AT shuangniyu krasrelatednoncodingrnasinpancreaticductaladenocarcinoma
AT yihuima krasrelatednoncodingrnasinpancreaticductaladenocarcinoma
AT wuganzhao krasrelatednoncodingrnasinpancreaticductaladenocarcinoma
AT xianglanjin krasrelatednoncodingrnasinpancreaticductaladenocarcinoma
AT haiyanyang krasrelatednoncodingrnasinpancreaticductaladenocarcinoma
AT pingpingliu krasrelatednoncodingrnasinpancreaticductaladenocarcinoma
AT jiechen krasrelatednoncodingrnasinpancreaticductaladenocarcinoma
_version_ 1718392555916230656